Scientific Programme - 16th Meeting of the European Section of Oncological Urology (ESOU) (ESOU19)

View programme as: Grid view List view
Print: Print
Personal Planner

06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00

Congress Hall
Foyer
Room Tyrolka
Madrid

1. 06:00
2. 07:00
3. 08:00
4. 09:00
5. 10:00
6. 11:00
7. 12:00
8. 13:00
9. 14:00
10. 15:00
11. 16:00
12. 17:00
13. 18:00
14. 19:00
15. 20:00
16. 21:00
Congress Hall
1. Prostate Cancer III: Locally advanced disease
  
  Prostate Cancer III: Locally advanced disease
  
  08:00 - 10:10
  Prostate Cancer III: Locally advanced disease
  
  Sat 19 January
  08:00 - 10:10
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  A. Heidenreich, Cologne (DE)
  S. Joniau, Leuven (BE)
  
  08:00 - 08:15
  
  Reliability of PET CT in primary staging
  
  A. Briganti, Milan (IT)
  
  08:15 - 08:20
  
  Discussion
  
  08:20 - 09:05
  
  Treatment of positive pelvic lymph nodes: clinical case in MDT
  
  08:20 - 08:30
  
  Surgery
  
  A. Briganti, Milan (IT)
  
  08:30 - 08:40
  
  Radio hormonal therapy
  
  T. Wiegel, Ulm (DE)
  
  08:40 - 08:50
  
  Systemic treatments
  
  M. De Santis, Berlin (DE)
  
  08:50 - 09:00
  
  Genomics
  
  G. Kristiansen, Bonn (DE)
  
  09:00 - 09:05
  
  Discussion
  
  09:05 - 09:40
  
  How to deal with nightmare complications of surgery and radiotherapy
  
  09:05 - 09:15
  
  Fistulae
  
  G. Bislenghi, Leuven (BE)
  
  09:15 - 09:25
  
  Radiation cystitis
  
  M. Colombel, Lyon (FR)
  
  09:25 - 09:35
  
  Recurrent strictures
  
  R. Djinovic, Belgrade (RS)
  
  09:35 - 09:40
  
  Discussion
  
  09:40 - 10:00
  
  Panel discussion: Predictors of local regional recurrence
  
  Moderator :
  
  J.W. Moul, Durham (US)
  
  09:40 - 09:47
  
  N. Fossati, Milan (IT)
  
  09:47 - 09:54
  
  S. Joniau, Leuven (BE)
  
  09:54 - 10:00
  
  D. Pfister, Cologne (DE)
  
  10:00 - 10:10
  
  Discussion
2. Welcome & Opening address
  
  Welcome & Opening address
  
  08:30 - 08:55
  Welcome & Opening address
  
  Fri 18 January
  08:30 - 08:55
  
  Location:
  
  Congress Hall
  
  08:30 - 08:35
  
  Welcome
  
  M. Brausi, Modena (IT)
  
  08:35 - 08:40
  
  Welcome
  
  M. Babjuk, Prague (CZ)
  
  08:40 - 08:55
  
  Opening address: History and impact of ESOU in onco-urology
  
  M. Brausi, Modena (IT)
3. Renal cancer II: Locally advanced and metastatic
  
  Renal cancer II: Locally advanced and metastatic
  
  08:30 - 10:00
  Renal cancer II: Locally advanced and metastatic
  
  Sun 20 January
  08:30 - 10:00
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  A. Bex, Amsterdam (NL)
  O. Rodriguez Faba, Barcelona (ES)
  
  08:30 - 09:30
  
  Adjuvant therapy after nephrectomy for high risk RCC: Should we recommend it?
  
  08:30 - 08:40
  
  The urologist’s perspective
  
  A. Bex, Amsterdam (NL)
  
  08:40 - 08:50
  
  The oncologist’s perspective
  
  A. Bamias, Athens (GR)
  
  08:50 - 09:05
  
  Cytoreductive nephrectomy: What are the current recommendations?
  
  A. Mejean, Paris (FR)
  
  09:05 - 09:20
  
  Revolution in first line treatment for mRCC: Where do we stand?
  
  P.F.A. Mulders, Nijmegen (NL)
  
  09:20 - 09:30
  
  Discussion
  
  09:30 - 10:00
  
  Panel discussion of clinical cases: Advanced and metastatic RCC
  
  Case presenter :
  
  O. Rodriguez Faba, Barcelona (ES)
  
  Panel :
  
  A. Bex, Amsterdam (NL)
  
  P.F.A. Mulders, Nijmegen (NL)
  
  M. Staehler, Munich (DE)
4. Prostate Cancer I: Prevention, diagnosis and active surveillance
  
  Prostate Cancer I: Prevention, diagnosis and active surveillance
  
  08:55 - 10:15
  Prostate Cancer I: Prevention, diagnosis and active surveillance
  
  Fri 18 January
  08:55 - 10:15
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  M. Brausi, Modena (IT)
  M. Wirth, Dresden (DE)
  
  08:55 - 09:10
  
  Prostate cancer prevention: An update
  
  S.D. Brookman-May, Munich (DE)
  
  09:10 - 09:25
  
  Why genetic tests are not there yet
  
  J.W. Moul, Durham (US)
  
  09:25 - 09:50
  
  Debate: mp-MRI should be used routinely in patients with an elevated PSA (short) introductory case how to digest the Precision study- introduced by chair)
  
  09:25 - 09:35
  
  YES always
  
  C. Moore, London (GB)
  
  09:35 - 09:45
  
  NO only in selected cases
  
  N. Mottet, Saint-Étienne (FR)
  
  09:45 - 09:50
  
  Discussion
  
  09:50 - 10:10
  
  Definition and interpretation of PI-RADS 3 on mp-MRI: counselling patients
  
  09:50 - 10:00
  
  Radiologist
  
  J. Barentsz, Nijmegen (NL)
  
  10:00 - 10:10
  
  Urologist
  
  J.P. Radtke, Heidelberg (DE)
  
  10:10 - 10:15
  
  Discussion
5. Prostate cancer II
  
  Prostate cancer II
  
  10:15 - 13:00
  Prostate cancer II
  
  Fri 18 January
  10:15 - 13:00
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  B. Djavan, Vienna (AT)
  N. Mottet, Saint-Étienne (FR)
  
  10:15 - 10:30
  
  Risk stratification for active surveillance
  
  N. Mottet, Saint-Étienne (FR)
  
  10:30 - 10:35
  
  Discussion
  
  10:35 - 10:50
  
  The role of mpMRI in active surveillance : Case presentation and discussion
  
  10:35 - 10:42
  
  The role of mpMR in active surveillance : Case presentation and discussion
  
  J. Barentsz, Nijmegen (NL)
  
  10:42 - 10:50
  
  The role of mpMR in active surveillance : Case presentation and discussion
  
  A. Masson-Lecomte, Paris (FR)
  
  10:50 - 11:20
  
  Break
  
  11:20 - 12:10
  
  Treatment of GS 7 (3+4) in an MDT scenario: Case presentation and debate
  
  11:20 - 11:30
  
  Active surveillance
  
  M. Roobol, Rotterdam (NL)
  
  11:30 - 11:40
  
  Focal therapy
  
  C. Orczyk, London (GB)
  
  11:40 - 11:50
  
  Surgery
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  11:50 - 12:00
  
  Hypofractionation RT
  
  A. Bossi, Villejuif (FR)
  
  12:00 - 12:10
  
  Discussion
  
  12:10 - 13:00
  
  What is high quality local treatment in high risk localised prostate cancer?
  
  12:10 - 12:30
  
  Surgery
  
  S. Joniau, Leuven (BE)
  
  12:30 - 12:50
  
  Radiotherapy
  
  P.L. Nguyen, Boston (US)
  
  12:50 - 13:00
  
  Discussion
6. Penile cancer
  
  Penile cancer
  
  10:30 - 11:00
  Penile cancer
  
  Sat 19 January
  10:30 - 11:00
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  S.S. Minhas, London (GB)
  N. Nicolai, Milan (IT)
  
  10:30 - 10:40
  
  Minimally invasive inguinal lymphadenectomy
  
  J.M. Gaya Sopena, Barcelona (ES)
  
  10:40 - 11:00
  
  MDT case discussion: Multi modal treatment bulky disease
  
  Panel :
  
  M. De Santis, Berlin (DE)
  
  N. Nicolai, Milan (IT)
  
  G. De Meerleer, Ghent (BE)
7. Best of uro-oncology 2018
  
  Best of uro-oncology 2018
  
  10:30 - 11:30
  Best of uro-oncology 2018
  
  Sun 20 January
  10:30 - 11:30
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  A. Breda, Barcelona (ES)
  To be confirmed
  
  10:30 - 10:45
  
  Prostate cancer
  
  J.P.M. Sedelaar, Nijmegen (NL)
  
  10:45 - 11:00
  
  Urothelial cancer
  
  M. Stanik, Brno (CZ)
  
  11:00 - 11:15
  
  Renal cancer
  
  B. Akdogan, Ankara (TR)
  
  11:15 - 11:30
  
  Testis and penile cancer
  
  B.E. Ayres, London (GB)
8. Testis cancer
  
  Testis cancer
  
  11:00 - 12:10
  Testis cancer
  
  Sat 19 January
  11:00 - 12:10
  
  Location:
  
  Congress Hall
  
  11:00 - 11:15
  
  Molecular markers for staging and monitoring testis cancer
  
  A. Radtke, Bremen (DE)
  
  11:15 - 11:25
  
  Discussion
  
  11:25 - 11:55
  
  The role of RPLND in tumour marker negative stage 2 A–B: Pro/con
  
  11:25 - 11:40
  
  Pro
  
  P. Albers, Düsseldorf (DE)
  
  11:40 - 11:55
  
  Con
  
  T. Tandstad, Trondheim (NO)
  
  11:55 - 12:10
  
  Challenging the dogma in surgical treatment of testis cancer
  
  A. Heidenreich, Cologne (DE)
9. Prostate cancer IV : Advanced and metastatic disease
  
  Prostate cancer IV : Advanced and metastatic disease
  
  11:30 - 13:00
  Prostate cancer IV : Advanced and metastatic disease
  
  Sun 20 January
  11:30 - 13:00
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  A. Heidenreich, Cologne (DE)
  N. Mottet, Saint-Étienne (FR)
  
  11:30 - 11:45
  
  Oligo metastatic disease today - Diagnostic and treatment
  
  J.W. Moul, Durham (US)
  
  11:45 - 12:30
  
  Case presentation : How do I treat primary metastatic disease?
  
  11:45 - 11:55
  
  Systemic therapy alone
  
  J. Bellmunt, Barcelona (ES)
  
  11:55 - 12:05
  
  Surgery plus or minus radiotherapy
  
  A. Heidenreich, Cologne (DE)
  
  12:05 - 12:30
  
  Clinical case discussion
  
  12:30 - 12:45
  
  How do I treat CRPC ?
  
  A. Alcaraz, Barcelona (ES)
  
  12:45 - 12:50
  
  Discussion
  
  12:50 - 13:00
  
  Closing remarks
  
  M. Brausi, Modena (IT)
10. Urothelial cancer II
  
  Urothelial cancer II
  
  13:00 - 15:30
  Urothelial cancer II
  
  Sat 19 January
  13:00 - 15:30
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  M. Babjuk, Prague (CZ)
  J. Palou, Barcelona (ES)
  
  13:00 - 13:15
  
  Genetics in urothelial cancer
  
  S. Lerner, Houston (US)
  
  13:15 - 14:00
  
  Panel discussion: Challenging case : Low volume MIB
  
  Panel :
  
  G.N. Thalmann, Berne (CH)
  
  J. Bellmunt, Barcelona (ES)
  
  P.L. Nguyen, Boston (US)
  
  S. Lerner, Houston (US)
  
  14:00 - 14:35
  
  Optimising functional outcomes in radical cystectomy
  
  14:00 - 14:10
  
  Prostate sparing approaches
  
  R. Sanchez-Salas, Paris (FR)
  
  14:10 - 14:20
  
  Robotic nerve sparing RC
  
  J. Palou, Barcelona (ES)
  
  14:20 - 14:30
  
  Open nerve sparing RC
  
  A. Stenzl, Tübingen (DE)
  
  14:30 - 14:35
  
  Discussion
  
  14:35 - 14:45
  
  Conservative management of upper tract urinary cancer
  
  A. Breda, Barcelona (ES)
  
  14:45 - 14:50
  
  Discussion
  
  14:50 - 15:05
  
  POUT Trial – Final result
  
  R. Jones, Glasgow (GB)
  
  15:05 - 15:10
  
  Discussion
  
  15:10 - 15:25
  
  New perspectives in UUT Tcc Treatment
  
  M. Rouprêt, Paris (FR)
  
  15:25 - 15:30
  
  Discussion
11. Renal cancer I: Localised: Diagnosis
  
  Renal cancer I: Localised: Diagnosis
  
  13:45 - 16:10
  Renal cancer I: Localised: Diagnosis
  
  Fri 18 January
  13:45 - 16:10
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  H.P.A.M. Van Poppel, Leuven (BE)
  A. Volpe, Novara (IT)
  
  13:45 - 14:05
  
  Diagnosis and treatment of cystic renal masses
  
  13:45 - 13:55
  
  Classification and role of cross-sectional imaging (CT/MRI)
  
  J. Walz, Marseille (FR)
  
  13:55 - 14:05
  
  Role of contrast enhanced ultrasound
  
  J. Rübenthaler, Munich (DE)
  
  14:05 - 14:40
  
  Case presentation and debate Cystic renal tumors: what is the best surgical approach for partial nephrectomy?
  
  14:05 - 14:15
  
  Open
  
  H.P.A.M. Van Poppel, Leuven (BE)
  
  14:15 - 14:25
  
  Laparoscopy
  
  To be confirmed
  
  14:25 - 14:35
  
  Robotic
  
  R. Nair, London (GB)
  
  14:35 - 14:40
  
  Discussion
  
  14:40 - 15:10
  
  Debate T2 renal tumors: what is the best surgical treatment?
  
  14:40 - 14:50
  
  Radical nephrectomy
  
  P.F.A. Mulders, Nijmegen (NL)
  
  14:50 - 15:00
  
  Partial nephrectomy
  
  C.K. Bensalah, Rennes (FR)
  
  15:00 - 15:10
  
  Discussion
  
  15:10 - 15:40
  
  Panel discussion of clinical cases: Localized RCC
  
  Moderators :
  
  A. Alcaraz, Barcelona (ES)
  
  J.P.M. Sedelaar, Nijmegen (NL)
  
  Panel :
  
  C.K. Bensalah, Rennes (FR)
  
  R. Nair, London (GB)
  
  A. Mottrie, Aalst (BE)
  
  15:40 - 16:10
  
  Intraperitoneal vs extraperitoneal robotics/lap partial nephrectomy
  
  15:40 - 15:50
  
  Intraperitoneal PN - when and how?
  
  A. Mottrie, Aalst (BE)
  
  15:50 - 16:00
  
  The extraperitoneal approach – when and how?
  
  F. Porpiglia, Turin (IT)
  
  16:00 - 16:10
  
  Discussion
12. ESU Course on the treatment of localised and locally advanced prostate cancer
  
  ESU Course on the treatment of localised and locally advanced prostate cancer
  
  15:40 - 18:30
  ESU Course on the treatment of localised and locally advanced prostate cancer
  
  Sat 19 January
  15:40 - 18:30
  
  Location:
  
  Congress Hall
  
  Chair:
  
  S. Joniau, Leuven (BE)
  
  15:40 - 15:45
  
  European School of Urology: A unique possibility for urological education
  
  S. Joniau, Leuven (BE)
  
  15:45 - 15:50
  
  Introduction and aims
  
  S. Joniau, Leuven (BE)
  
  15:50 - 16:10
  
  Diagnosis, biopsy and staging of prostate cancer
  
  S. Joniau, Leuven (BE)
  
  16:10 - 16:25
  
  Planning the surgical procedure and estimating surgical risk
  
  A. Heidenreich, Cologne (DE)
  
  16:25 - 16:40
  
  Open nerve-sparing radical prostatectomy for localised PCa (video)
  
  A. Heidenreich, Cologne (DE)
  
  16:40 - 16:55
  
  Pelvic lymphadenectomy in the primary and salvage setting (video)
  
  S. Joniau, Leuven (BE)
  
  16:55 - 17:15
  
  Modern radiotherapy for localised and locally advanced prostate cancer
  
  G. De Meerleer, Ghent (BE)
  
  16:55 - 17:05
  
  Salvage radical prostatectomy (video)
  
  A. Heidenreich, Cologne (DE)
  
  17:15 - 17:25
  
  Active surveillance
  
  S. Joniau, Leuven (BE)
  
  17:15 - 17:30
  
  Discussion
  
  17:25 - 17:40
  
  Break
  
  17:40 - 18:00
  
  Treatment of biochemical recurrence post-radiotherapy: Salvage radical prostatectomy/salvage vesiculectomy (video)
  
  A. Heidenreich, Cologne (DE)
  
  18:00 - 18:25
  
  Treatment of biochemical recurrence post-surgery: Role of PET imaging; Adjuvant and salvage RT
  
  G. De Meerleer, Ghent (BE)
  
  18:00 - 18:20
  
  Treatment of biochemical recurrence post-surgery: Role of PET imaging/Adjuvant and salvage RT
  
  G. De Meerleer, Ghent (BE)
  
  18:20 - 18:30
  
  Discussion and close
  
  S. Joniau, Leuven (BE)
13. Urothelial and bladder cancer I: Diagnosis & staging
  
  Urothelial and bladder cancer I: Diagnosis & staging
  
  16:30 - 18:00
  Urothelial and bladder cancer I: Diagnosis & staging
  
  Fri 18 January
  16:30 - 18:00
  
  Location:
  
  Congress Hall
  
  Chairs:
  
  M. Colombel, Lyon (FR)
  G.N. Thalmann, Berne (CH)
  
  16:30 - 16:40
  
  MRI for bladder cancer staging
  
  V. Panebianco, Rome (IT)
  
  16:40 - 16:50
  
  Is en-bloc TUR the best staging tool?
  
  B. Malavaud, Toulouse (FR)
  
  16:50 - 17:00
  
  Confocal laser endomicroscopy (Cellvizio) for the diagnosis of Cis and Dysplasia
  
  M. Brausi, Modena (IT)
  
  17:00 - 17:10
  
  Discussion
  
  17:10 - 17:20
  
  Epigenetics in NMIBC
  
  J.A. Witjes, Nijmegen (NL)
  
  17:20 - 17:30
  
  Discussion
  
  -
  
  Clinical case presentation on NMIBC
  
  Moderators :
  
  M. Babjuk, Prague (CZ)
  
  J. Palou, Barcelona (ES)
  
  Panel :
  
  M. Colombel, Lyon (FR)
  
  B. Malavaud, Toulouse (FR)
  
  E. Xylinas, Paris (FR)
  
  A. Brisuda, Prague (CZ)
  
  J.A. Witjes, Nijmegen (NL)
Foyer
1. Break
  
  Break
  
  10:00 - 10:30
  Break
  
  Sun 20 January
  10:00 - 10:30
  
  Location:
  
  Foyer
2. Break
  
  Break
  
  10:10 - 10:30
  Break
  
  Sat 19 January
  10:10 - 10:30
  
  Location:
  
  Foyer
3. Lunch
  
  Lunch
  
  12:10 - 13:00
  Lunch
  
  Sat 19 January
  12:10 - 13:00
  
  Location:
  
  Foyer
4. Lunch
  
  Lunch
  
  13:00 - 13:45
  Lunch
  
  Fri 18 January
  13:00 - 13:45
  
  Location:
  
  Foyer
5. Break
  
  Break
  
  15:30 - 15:40
6. Break
  
  Break
  
  16:10 - 16:30
  Break
  
  Fri 18 January
  16:10 - 16:30
  
  Location:
  
  Foyer
Room Tyrolka
1. STEPS (Session To Evaluate ProgresS) programme - Closed programme: Participation by invitation only!
  
  STEPS (Session To Evaluate ProgresS) programme - Closed programme: Participation by invitation only!
  
  16:00 - 18:00
  STEPS (Session To Evaluate ProgresS) programme - Closed programme: Participation by invitation only!
  
  Sat 19 January
  16:00 - 18:00
  
  Location:
  
  Room Tyrolka
  
  Chair:
  
  M. Brausi, Modena (IT)
  
  Prostate cancer table
  
  Chair
  
  J.W. Moul, Durham (US)
  
  ESOU Board Member
  
  P.L. Chlosta, Cracow (PL)
  
  Bladder cancer table
  
  Chair
  
  S. Lerner, Houston (US)
  
  ESOU Board Member
  
  E. Xylinas, Paris (FR)
  
  Renal cancer table
  
  Chair
  
  P.F.A. Mulders, Nijmegen (NL)
  
  ESOU Board Member
  
  A. Volpe, Novara (IT)
  
  Testis cancer table
  
  Chair
  
  D. Pfister, Cologne (DE)
  
  ESOU Board Member
  
  J.P.M. Sedelaar, Nijmegen (NL)
Madrid
1. Hands-on training course on prostate MRI reading for urologists
  
  Hands-on training course on prostate MRI reading for urologists
  
  09:00 - 12:30
  Hands-on training course on prostate MRI reading for urologists
  
  Sat 19 January
  09:00 - 12:30
  
  Location:
  
  Madrid
  
  Chair:
  
  C. Moore, London (GB)
  
  09:00 - 09:15
  
  The importance of prostate MRI to the urologist Overview of the course
  
  C. Moore, London (GB)
  
  09:15 - 09:45
  
  Introduction to MRI sequences, scoring systems, PI-RADS
  
  J. Barentsz, Nijmegen (NL)
  
  09:45 - 10:15
  
  What to look for?: Interactive case discussion – reporting MRI using PI-RADS
  
  V. Panebianco, Rome (IT)
  
  10:15 - 10:20
  
  Introduction to the MIM software for MRI interpretation
  
  C. Moore, London (GB)
  
  10:20 - 10:50
  
  Assessment: Hand - on baseline assessment of MRI interpretation
  
  10:50 - 11:20
  
  Review of assessment scans
  
  J. Barentsz, Nijmegen (NL)
  
  11:20 - 11:50
  
  Assessment: Hand - on baseline assessment of MRI interpretation
  
  11:50 - 12:20
  
  Review of assessment scans
  
  V. Panebianco, Rome (IT)
  
  12:20 - 12:30
  
  Close
  
  L. Budäus, Hamburg (DE)

Congress Hall

Foyer

Room Tyrolka

Madrid

Congress Hall

Foyer

Room Tyrolka

Madrid